Go-To-Market Success:
The Role of Capital Preservation in Life Science Research and Diagnostic Consumable Manufacturing
About this webinar
In this webinar, Patrick Tuohy will address a critical question encountered by most life science and diagnostic companies: Should the development and/or manufacturing of products be outsourced or in-sourced? The webinar delves into how diagnostic and life science companies can save capital and reduce time to market by outsourcing their development and manufacturing needs.
The speakers will explore the benefits of leveraging pilot line capabilities for life science and diagnostic companies seeking to commercialize their novel innovations. The pilot line capability at SCHOTT MINIFAB consists of a purpose-built infrastructure, backed by decades of manufacturing know-how.
This enables the transformation of clients’ products from initial assembled units (for feasibility testing) to the first commercial articles that contribute to improving patient health and well-being. The speakers will also discuss other outsourcing benefits, along with some drawbacks and strategies to mitigate them.
Register for this webinar to discover strategies for companies to save capital and reduce time to market by outsourcing development and manufacturing needs for product development.
Who should attend
- Product Developers
- Research & Development (R&D) Managers/Directors
- Procurement Managers/Directors
- Supply Chain Managers
- Product Managers
- Chief Scientific Officer (CSO) or Chief Technology Officer (CTO)
- Business Development Managers/Directors
- Diagnostic and life science research companies
What you will learn
- Pilot line capabilities at SCHOTT MINIFAB
- Benefits of outsourcing, including reduced capital investment and faster time to market
- Factors to consider when weighing up the costs of outsourcing vs. insourcing
Featured Speakers
Dr. James Downs
Leveraging a 20+ year career across biopharmaceutical and medical device chains, Dr. James Downs is passionate about helping companies develop highly complex point-of-care and clinical diagnostic cartridges and components. With a BS in Economics from the University of Southern Mississippi and an MBA and PhD in Economics from HHL Leipzig Graduate School of Business, he previously held management roles with Pfizer Inc., led multiple medical device startups and is now leading SCHOTT MINIFAB’s business development.
Patrick Tuohy
Patrick Tuohy holds a BSc in Applied Physics from the University of Limerick, Ireland. With over 15 years of experience in developing and commercializing microfluidic instruments and consumables, he has contributed significantly to the life science and diagnostics industries in both Ireland and Australia. Patrick is passionate about helping companies realize their visions to enhance human health and well-being.
Partner for this event
SCHOTT MINIFAB
SCHOTT MINIFAB, a contract manufacturer, partners with diagnostic and life science research firms, offering rapid and efficient design, development and manufacturing of IVD consumables. Our integrated approach ensures streamlined processes from concept to commercialization, leveraging cutting-edge technologies and scalable production capabilities for the highest possible quality. Our diverse solutions encompass functional coatings, microarray printing and polymer microfluidic integration, addressing a wide range of technical needs while reducing overall costs. With a legacy of over 130 years in problem-solving, our team of passionate professionals empowers product developers and researchers worldwide, realizing innovations that improve patient care and advance scientific breakthroughs.
Related webinars
More from SCHOTT.
Microfluidic Devices with Glass: New Trends for Diagnostic and Life Science Applications
Advancing In Vitro Diagnostics and Accelerating Drug Discovery with the Latest Microarray Technologies
Exploring Porous Glass as a Cutting-Edge Substrate for Life Science Applications